Cargando…
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
BACKGROUND: Combination antiretroviral (AR) therapy continues to be the mainstay for HIV treatment. However, antiretroviral drug nonadherence can lead to the development of resistance and treatment failure. We have designed nanoparticles (NP) that contain three AR drugs and characterized the size, s...
Autores principales: | Destache, Christopher J, Belgum, Todd, Christensen, Keith, Shibata, Annemarie, Sharma, Akhilesh, Dash, Alekha |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807870/ https://www.ncbi.nlm.nih.gov/pubmed/20003214 http://dx.doi.org/10.1186/1471-2334-9-198 |
Ejemplares similares
-
Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis
por: Khandalavala, Karl, et al.
Publicado: (2017) -
Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis
por: Mandal, Subhra, et al.
Publicado: (2017) -
Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study
por: Mandal, Subhra, et al.
Publicado: (2022) -
Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain
por: Patel, Bhavin K, et al.
Publicado: (2018) -
Injectable Nano Drug Delivery Systems for the Treatment of Breast Cancer
por: Kafle, Urmila, et al.
Publicado: (2022)